Skip to main content
Log in

Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulfate

  • Originals
  • Published:
Rheumatology International Aims and scope Submit manuscript

Summary

Chondroitin sulfate was administered orally to six healthy volunteers, six patients with rheumatoid arthritis and six patients with osteoarthritis. Blood was collected at intervals before and after treatment and the glycosaminoglycan concentration was analyzed in serum using a sensitive assay based on the metachromatic reaction with 1,9-dimethylmethylene blue. The glycosaminoglycan concentration in serum before and after ingestion of chondroitin sulfate was statistically unchanged in all of the subjects studied. We suggest that chondroprotection by orally administered chondroitin sulfate is a biologically and pharmacologically unfounded theory. Any possible benefit to osteoarthritic patients after ingestion of chondroitin sulfate should be sought at the gastrointestinal rather than at the plasmatic or articular cartilage level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pipitone VR (1991) Chondroprotection with chondroitin sulfate. Drugs Exp Clin Res 17:3–7

    Google Scholar 

  2. Paroli E, Antonilli L, Biffoni M (1991) A pharmacological approach to glycosaminoglycans. Drugs Exp Clin Res 17:9–19

    Google Scholar 

  3. Fioravanti A, Franci A, Anselmi F, Fattorini L, Marcolongo R (1991) Clinical efficacy and tolerance of galactosoaminoglucuronoglycan sulfate in the treatment of osteoarthritis. Drugs Exp Clin Res 17:41–44

    Google Scholar 

  4. Oliviero U, Sorrentino GP, De Paola P, Tranfaglia E, D'Alessandro A, Carifi S, Porfido FA, Cerio R, Grasso AM, Policicchio D, Di Grezia F, Sorrentino P, Lingetti M (1991) Effects of the treatment with matrix on elderly people with chronic articular degeneration. Drugs Exp Clin Res 17:45–51

    Google Scholar 

  5. Rovetta G (1991) Galactosaminoglycuronoglycan sulfate (Matrix) in therapy of tibiofibular osteoarthritis of the knee. Drugs Exp Clin Res 17:53–57

    Google Scholar 

  6. Soldani G, Romagnoli J (1991) Experimental and clinical pharmacology of glycosaminoglycans. Drugs Exp Clin Res 17:81–85

    Google Scholar 

  7. Palmieri L, Conte A, Giovannini L, Lualdi P, Ronca G (1990) Metabolic fate of exogenous chondroitin sulfate in the experimental animal. Arzneimittelforschung/Drug Res 40:319–323

    Google Scholar 

  8. Conte A, Palmieri L, Segnini D, Ronca G (1991) Metabolic fate of partially depolymerized chondroitin sulfate administered to the rat. Drugs Exp Clin Res 17:27–33

    Google Scholar 

  9. Conte A, de Bernardi M, Palmieri L, Lualdi P, Mautone G, Ronca G (1991) Metabolic fate of exogenous chondroitin sulfate in man. Arzneimittelforschung/Drug Res 41:768–772

    Google Scholar 

  10. Dohlman CH (1956) The fate of the sulfate group of chondroitin sulfate after administration to rats. Acta Physiol Scand 37:220–234

    Google Scholar 

  11. Andermann G, Dietz M (1982) The influence of the route of administration on the bioavailability of an endogenous macro-molecule: chondroitin sulfate (CSA). Eur J Drug Metab Pharmacokinet 7:11–16

    Google Scholar 

  12. Konador A, Kawiak J (1977) Changes in chondroitin sulfate concentration in rabbit blood plasma depending on the method of its administration. Arch Immunol Ther Exp (Warsz) 25:895–903

    Google Scholar 

  13. Konador A, Kawiak J (1976) Distribution of radioactivity in the mouse organism after administration of 35S-chondroitin sulphate. Folia Biol (Krakow) 24:177–190

    Google Scholar 

  14. Dziewiatkowski DD (1956) Some aspects of the metabolism of chondroitin sulfate-35S in the rat. J Biol Chem 223:239–249

    Google Scholar 

  15. Farndale RW, Buttle DJ, Barrett AJ (1986) Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883:173–177

    Google Scholar 

  16. International Union of Pure and Applied Chemistry, Analytical Chemistry Division (1976) Nomenclature, symbols, units and their usage in spectrochemical analysis-II. Data interpretation. Anal Chem 48:2294–2296

    Google Scholar 

  17. Cowman MK, Slahetka MF, Hittner DM, Kim J, Forino M, Gadelrab G (1984) Polyacrylamide-gel electrophoresis and Alcian Blue staining of sulphated glycosaminoglycan oligosaccharides. Biochem J 221:707–716

    Google Scholar 

  18. Baici A, Lang A (1990) Cathepsin B secretion by rabbit articular chondrocytes: modulation by cycloheximide and glycosaminoglycans. Cell Tissue Res 259:567–573

    Google Scholar 

  19. Hampson IN, Gallagher JT (1984) Separation of radiolabelled glycosaminoglycan oligosaccharides by polyacrylamide-gel electrophoresis. Biochem J 221:697–705

    Google Scholar 

  20. Templeton DM (1988) The basis and applicability of the dimethylmethylene blue binding assay for sulfated glycosaminoglycans. Connect Tissue Res 17:23–32

    Google Scholar 

  21. Kantor TG, Schubert M (1957) A method for the desulfation of chondroitin sulfate. J Am Chem Soc 79:152–153

    Google Scholar 

  22. Németh-Csóka M, Kajtár M, Kajtár J (1977) The role of sulphation of glycosaminoglycans in their structural and functional characteristics. Connect Tissue Res 5:1–6

    Google Scholar 

  23. Chasseaud LF, Fry BJ, Saggers VH, Sword IP, Hathway DE (1972) Studies on the possible absorption of a sulphated glycopeptide (GLPS) in relation to its mode of action. Biochem Pharmacol 21:3121–3130

    Google Scholar 

  24. Bollet AJ, Seraydarian MW, Simpson WF (1957) Acid mucopolysaccharides in normal serum. J Clin Invest 36:1328–1332

    Google Scholar 

  25. Staprans I, Felts JM (1985) Isolation and characterization of glycosaminoglycans in human plasma. J Clin Invest 76:1984–1991

    Google Scholar 

  26. Bower L, Braven J, Manley G (1988) The isolation and characterization of glycosaminoglycans in normal human serum. J Pharm Biomed Anal 6:67–74

    Google Scholar 

  27. Juvani M, Friman C, Ranta H, Wegelius O (1975) Isolation and characterization of undersulfated chondroitin-4-sulphate from normal human plasma. Biochim Biophys Acta 411:1–10

    Google Scholar 

  28. Wood KM, Wusteman FS, Curtis CG (1973) The degradation of intravenously injected chondroitin 4-sulphate in the rat. Biochem J 134:1009–1013

    Google Scholar 

  29. Wood KM, Curtis CG, Powell GM, Wusteman FS (1973) The metabolic fate of chondroitin 4-[35S]sulphate in the rat. Biochem Soc Trans 1:840–842

    Google Scholar 

  30. Revell PA, Muir H (1972) The excretion and degradation of chondroitin 4-sulphate administered to guinea pigs as free chondroitin sulphate and as proteoglycan. Biochem J 130:597–606

    Google Scholar 

  31. Kaplan D, Meyer K (1962) The fate of injected mucopolysaccharides. J Clin Invest 41:743–749

    Google Scholar 

  32. Buermann CW, Oronsky AL, Horowitz MI (1979) Chondroitin sulfate-degrading enzymes in human polymorphonuclear leukocytes: characteristics and evidence for concerted mechanisms. Arch Biochem Biophys 193:277–283

    Google Scholar 

  33. Salkie ML (1971) The acid glycosaminoglycan-degrading activity of normal human serum. Clin Chim Acta 31:300–302

    Google Scholar 

  34. Fishman WH, Kato K, Anstiss CL, Green S (1967) Human serum β-glucuronidase; its measurement and some of its properties. Clin Chim Acta 15:435–447

    Google Scholar 

  35. Niebes P, Schifflers MH (1975) Micromethod for the determination of glycosaminoglycans in the serum. Results from the serum of healthy and varicose subjects. Clin Chim Acta 62:195–202

    Google Scholar 

  36. Larking PW (1989) Total glycosaminoglycans in the plasma of adults: effects of age and gender, and relationship to plasma lipids: a preliminary study. Biochem Med Metab Biol 42:192–197

    Google Scholar 

  37. Toyoda H, Yamanashi S, Hakamada Y, Shinomiya K, Imanari T (1989) Profile analysis of chondroitin sulfates in human urine and serum. Chem Pharm Bull (Tokyo) 37:1627–1628

    Google Scholar 

  38. Wilson TH (1962) Intestinal absorption. Saunders, Philadelphia London, Chapter 3

    Google Scholar 

  39. Schanker LS, Tocco DJ, Brodie BB, Hogben CAM (1958) Absorption of drugs from the rat small intestine. J Pharmacol Exp Ther 123:81–88

    Google Scholar 

  40. Fischer A, Astrup T (1939) On the administration of heparin per os. Proc Soc Exp Biol Med 42:81–82

    Google Scholar 

  41. Loomis TA (1959) Absorption of heparin from the intestine. Proc Soc Exp Biol Med 101:447–449

    Google Scholar 

  42. Salafsky B, Loomis TA (1960) Intestinal absorption of a modified heparin. Proc Soc Exp Biol Med 104:62–65

    Google Scholar 

  43. Windsor E, Cronheim GE (1961) Gastro-intestinal absorption of heparin and synthetic heparinoids. Nature 190:263–264

    Google Scholar 

  44. Engel RH, Riggi SJ (1969) Intestinal absorption of heparin: a study of the interactions of components of oil-in-water emulsions. J Pharm Sci 58:1372–1375

    Google Scholar 

  45. Engel RH, Fahrenbach MJ (1968) Intestinal absorption of heparin in the rat and gerbil. Proc Soc Exp Biol Med 129:772–777

    Google Scholar 

  46. Engel RH, Riggi SJ (1969) Effect of sulfated and sulfonated surfactants on the intestinal absorption of heparin. Proc Soc Exp Biol Med 130:879–884

    Google Scholar 

  47. Liau YH, Galicki N, Horowitz MI (1981) Degradation of chondroitin 4-sulfate by rat stomach exoglycosidases, sulfohydrolase and hyaluronidase-like enzymes. Digestion 21:117–124

    Google Scholar 

  48. Liau YH, Horowitz MI (1974) Desulfation and depolymerization of chondroitin 4-sulfate and its degradation products by rat stomach, liver and small intestine. Proc Soc Exp Biol Med 146:1037–1043

    Google Scholar 

  49. Liau YH, Horowitz MI (1973) Desulfation of sulfated polyanions by rat gastric mucosa. Proc Soc Exp Biol Med 144:13–16

    Google Scholar 

  50. Liau YH, Galicki NI, Horowitz MI (1978) Heterogeneity of rat rib chondroitin sulfate and susceptibility to rat gastric chondrosulfatase. Biochim Biophys Acta 539:315–323

    Google Scholar 

  51. Segre G (1986) Aspetti farmacologici dei glucosaminoglicani. Minerva Med 77:1859–1864

    Google Scholar 

  52. Baici A, Bradamante P (1984) Interaction between human leukocyte elastase and chondroitin sulfate. Chem Biol Interact 51:1–11

    Google Scholar 

  53. Avila JL, Convit J (1976) Physicochemical characteristics of the glycosaminoglycan-lysosomal enzyme interaction in vitro. A model of control of leucocytic lysosomal activity. Biochem J 160:129–136

    Google Scholar 

  54. Navia MA, McKeever BM, Springer JP, Lin TY, Williams HR, Fluder EM, Dorn CP, Hoogsteen K (1989) Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-Å resolution. Proc Natl Acad Sci USA 86:7–11

    Google Scholar 

  55. Baici A (1990) Properties of inhibitors of extracellular matrix-degrading endopeptidases in rheumatic diseases. Habilitationsschrift, University of Zurich, pp 145–154

  56. Crivelli E, Voy ED (1987) Arthrose des grandes articulations. Étude de phase IV sur l'action de doses orales de sulfate de chondroïtine chez 255 patients. Der Informierte Arzt 8:78–82

    Google Scholar 

  57. Langman MJS (1991) Peptic ulcers and non-steroidal anti-inflammatory drugs. Eur J Rheumatol Inflamm 11:13–18

    Google Scholar 

  58. Prino G, Lietti A, Paglialunga S (1971) Inhibition of gastric peptic activity by a new sulfate glycopeptide (GLPS). Arzneimittelforschung/Drug Res 21:918–921

    Google Scholar 

  59. Prino G, Paglialunga S, Nardi G, Lietti A (1971) Inhibition of experimentally-induced gastric ulcers in the rat by a new sulfated glycopeptide. Eur J Pharmacol 15:119–126

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baici, A., Hörler, D., Moser, B. et al. Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulfate. Rheumatol Int 12, 81–88 (1992). https://doi.org/10.1007/BF00290259

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00290259

Key words

Navigation